Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After Adjuvant Chemotherapy in TNBC 03/17/2021 INTERVENTIONAL unchanged 1,988.85 0 Removal of Intrauterine Retained Products of Conception (RPOC) After Miscarriage Guided by Hysteroscopy Trial. A Randomized Controlled Trial. 03/18/2021 INTERVENTIONAL unchanged 1,987.85 0 Pregnancy Exercise Mode Effect on Childhood Obesity 03/18/2021 INTERVENTIONAL unchanged 1,987.85 0 Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer 03/19/2021 INTERVENTIONAL unchanged 1,986.85 0 CMP-001 and Pre-operative Stereotactic Body Radiation Therapy (SBRT) in Early Stage Triple Negative Breast Cancer (TNBC) 03/19/2021 INTERVENTIONAL unchanged 1,986.85 0 Multi-Gyn ActiGel Plus for Treatment of Bacterial Vaginosis 03/19/2021 INTERVENTIONAL unchanged 1,986.85 0 Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo 03/19/2021 INTERVENTIONAL unchanged 1,986.85 0 Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer 03/23/2021 INTERVENTIONAL unchanged 1,982.85 0 Digitally Distributed Yoga for Women Treated for Breast Cancer 03/23/2021 INTERVENTIONAL unchanged 1,982.85 0 The Use of Expandeded Mesenchymal Stromal Cells (MSC) in Premature Ovarian Failure (POF) in Adult Humans 03/24/2021 INTERVENTIONAL unchanged 1,981.85 0 Breast Cancer, Reasoning, and Activity Intervention 03/25/2021 INTERVENTIONAL unchanged 1,980.85 0 Cognitive Training and Brain Stimulation in Women With Post-chemotherapy Cognitive Impairment 03/26/2021 INTERVENTIONAL unchanged 1,979.85 0 Use of Compression Bandages in the Prevention of Post-mastectomy Lymphoceles 03/29/2021 INTERVENTIONAL unchanged 1,976.85 0 Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens 03/29/2021 INTERVENTIONAL unchanged 1,976.85 0 Maternal Stress on Human Milk and Infant Outcomes 03/29/2021 INTERVENTIONAL unchanged 1,976.85 0 Breast Elasticity Imaging During Neoadjuvant Chemotherapy 04/01/2021 INTERVENTIONAL unchanged 1,973.85 0 The Heart Outcomes in Pregnancy Expectations (H.O.P.E) Registry 04/01/2021 OBSERVATIONAL unchanged 1,973.85 0 Prospective Study of Pregnancy in Women With Cystic Fibrosis 04/02/2021 OBSERVATIONAL unchanged 1,972.85 0 GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study 04/02/2021 OBSERVATIONAL unchanged 1,972.85 0 Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry 04/02/2021 OBSERVATIONAL unchanged 1,972.85 0 Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System 04/02/2021 OBSERVATIONAL unchanged 1,972.85 0 Trajectory of Psychological Distress Among Infertility Women 04/02/2021 INTERVENTIONAL unchanged 1,972.85 0 Post-Market Clinical Follow-Up onTVT EXACT® Continence System 04/02/2021 OBSERVATIONAL unchanged 1,972.85 0 Non-interventional Study to Collect Real-world Clinical and Patient-reported Outcomes in Ovarian Cancer 04/05/2021 OBSERVATIONAL unchanged 1,969.85 0 Effects of Low-Level Laser Therapy on Mouth Opening and Surface Electromyography in Temporomandibular Disorders 04/05/2021 INTERVENTIONAL unchanged 1,969.85 0 Clinical Response and Toxicity of Hypo-fractionated Chemoradiotherapy in Cervix Cancer 04/05/2021 INTERVENTIONAL unchanged 1,969.85 0 A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer 04/05/2021 INTERVENTIONAL unchanged 1,969.85 0 Estrogen Administration for the Treatment of NASH in Postmenopausal Women 04/06/2021 INTERVENTIONAL unchanged 1,968.85 0 A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care 04/08/2021 INTERVENTIONAL unchanged 1,966.85 0 Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for Human Epidermal Growth Factor Receptor 2 (HER2) Negative Early Breast Cancer Patients 04/08/2021 INTERVENTIONAL unchanged 1,966.85 0 The Effect of Acupuncture on Cancer-Related Cognitive Difficulties 04/08/2021 INTERVENTIONAL unchanged 1,966.85 0 Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care 04/09/2021 INTERVENTIONAL unchanged 1,965.85 0 A Study of Prucalopride in Breastfeeding Women With Constipation 04/09/2021 OBSERVATIONAL unchanged 1,965.85 0 Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia 04/09/2021 INTERVENTIONAL unchanged 1,965.85 0 Phase III Study :SHR6390/Placebo Combined With Endocrine Therapy for the Adjuvant Treatment of Hormone Receptor Positive,Human Epidermal Receptor 2 Negative 04/13/2021 INTERVENTIONAL unchanged 1,961.85 0 TCM as an Adjuvant Treatment in Breast Cancer Patients 04/14/2021 INTERVENTIONAL unchanged 1,960.85 0 Evaluation of Cortisol and Bile Acids Metabolism in Obese Patients 04/14/2021 OBSERVATIONAL unchanged 1,960.85 0 Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome 04/14/2021 INTERVENTIONAL unchanged 1,960.85 0 Fresh RX: NHS 2020 04/14/2021 INTERVENTIONAL unchanged 1,960.85 0 Randomized Comparison Between Sentinel Lymph Node Biopsy and Lymph Node Dissection in Early Stage Endometrial Cancer 04/15/2021 INTERVENTIONAL unchanged 1,959.85 0 Multi-layer Data to Improve Diagnosis, Predict Therapy Resistance and Suggest Targeted Therapies in HGSOC 04/15/2021 INTERVENTIONAL unchanged 1,959.85 0 Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications 04/15/2021 OBSERVATIONAL unchanged 1,959.85 0 A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer 04/19/2021 INTERVENTIONAL unchanged 1,955.85 0 Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma 04/19/2021 INTERVENTIONAL unchanged 1,955.85 0 NEUROIMAGING OF ADOLESCENT BORDERLINE PERSONALITY DISORDER WITH AND WITHOUT POST-TRAUMATIC STRESS DISORDER 04/21/2021 INTERVENTIONAL unchanged 1,953.85 0 Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts 04/22/2021 OBSERVATIONAL unchanged 1,952.85 0 Telehealth Weight Loss Program for Breast Cancer Survivors 04/22/2021 INTERVENTIONAL unchanged 1,952.85 0 Automated Cervical Cancer Screening Using a Smartphone-based Artificial Intelligence Classifier 04/26/2021 INTERVENTIONAL unchanged 1,948.85 0 Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI) 04/27/2021 INTERVENTIONAL unchanged 1,947.85 0 Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH) 04/27/2021 INTERVENTIONAL unchanged 1,947.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology